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background: Anticipating adverse outcomes guides timely decisions, helping patients plan, but can be challenging in heart failure (HF).
Methods: All faculty and trainees in internal medicine and cardiology at our institution were surveyed about palliative care and asked to estimate 
survival for standardized patients: 1) a 59 year old male with stage IV lung cancer; 2) a 79 year-old woman with New York Heart Association (NYHA) 
class 4 HF symptoms and preserved ejection fraction (HFpEF); 3) a 40 year-old man with NYHA class 3 HF symptoms and reduced EF of 20% (HFrEF). 
Physician predictions were compared to model predictions from the SEER-Medicare database and the Seattle Heart Failure Score.
results: Of 381 surveyed, 293 (77%) responded. Physicians were more accurate in prognostication for lung cancer than for HF (estimates within 
two-fold for 72% vs. 48%, respectively; p<0.001 ). Cardiology faculty were most optimistic about survival in both HFpEF and HFrEF but not lung 
cancer compared to other physicians (Table). Compared to objective models, cardiologists were more accurate than others for HFpEF mortality but 
no different than others for HFrEF mortality. In HF compared to lung cancer, all physicians were less comfortable discussing palliative care (1-5 Likert 
scale: mean 2.7±1.0 vs 2.0±0.9, p<0.0001) and prognosis (3.1±1.0 vs 2.6±1.1, p<0.0001).
conclusions: Less than half of physicians accurately predict HF survival, with cardiologists most likely to predict longer survival in HF.
Comparison of 1-year and 5-year mortality prediction. Values are median% and interquartile range%.
Lung Cancer
1 Year Mortality
Lung Cancer
5 Year Mortality
HFpEF
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5 Year Mortality
HFrEF
1 Year Mortality
HFrEF
5 Year Mortality
Interns (n=77) 70, 50-80 95, 89-99 30, 20-53 80, 60-90 27.5, 15-50 60, 40-80
Residents (n=78) 75, 50-84 98, 90-100 40, 24-61 80, 60-95 37, 20-60 70.5, 50-90
PCPs (n=34) 70, 50-85 95, 89-99 38, 22-54 80, 70-90 49, 24-77 75, 51-94
Hospitalists (n=21) 65, 50-75 95, 95-100 50, 30-60 85, 79-95 30, 25-41 70, 50-83
Cardiology Fellows (n=21) 60, 30-75 90, 80-98 30, 16-50 75, 50-90 30, 13-50 55, 40-83
Cardiology Faculty (n=20) 67.5, 49-80 95.5, 91-99 25, 10-50 60, 41-80 20, 10-30 50, 40-60
Overall (n=254) 70, 50-80 95, 90-100 36, 20-51 80, 60-90 30, 19-50 65, 47-85
Model Predicted 80 99 35 88 17 61
